Reid Hoffman launches Manas AI, the beginning of the new drug discovery

Linkedin Coat of Directors and Vocabulary Reid Hoffman It became billing of his social business company, and has made profit bets included in companies Airbnb and while protecting the start of the nuclear fusion of Zynga Helion energy.

Hoffman dips with healthcare, due to the “wonderful and scary”, describes Manas AI.

Dr. Hoffman and Siddhartha Mukherjee, an oncologist and award-winning author of the Pulitzer, convert Company on Monday. Manas will use artificial intelligence to try to accelerate the process of drug discovery, starting with new treatments for aggressive cancer such as prostate cancer, lymphoma and triple breast cancer.

Developing new drugs is an expensive and complex process. It can take more than 10 years and cost millions of dollars to develop a single medication, according to a report Deloitte. Manas said that he will use his proprietary chemical library and the AI ​​filters to identify drug candidates faster, reduce the process of the expiry decade a few years.

“Most people have had friends, family, and so on, killed cancer or have been serious trouble of cancer,” Hoffman said CNBC in an interview this week. “We can have a tremendous difference around this, and this is the reason why AI can have a terrible difference, AI is a great reason for humanity.”

Manas collected $ 24.6 million in seed financing, guided General catalyst And with the participation of Hoffman Greylock, where the pair is. Hoffman has delved into AI in recent years. The Openai investor was an early investor, when the project was non-profit, and AR started turning the Mustafa Suleyman Deepmind with the co-creator. Last year, Suleyman joined MicrosoftWhere Hoffman is a member of the Council, as the CEO of a new unit called Microsoft AI. Several turning staff came together.

Manas also included cooperation MicrosoftAnd he will take advantage of the Azuri cloud computing platform. Hoffman, LinkedIn sold Microsoft 27 billion dollars, says ManaS spreads multiple additional tools in Microsoft, including some that are not available to the public in general.

Hoffman has worked with Mukherjee to create Manas for a year, although the process received vapor last month. Hoffman said the team was ready to publicly share his ambitions this week, the founding resources are in order.

The company has a long way before, and the drug finding market is very competitive. Other startups along with major pharmaceutical companies Eli Lilly, Pfizer and MerckAlas how the lever are making to speed up drugs and development.

Hoffman said he feels sure in Manas’s approach, even if it would be “absolutely happy” to see many companies bloom.

“We also bring a thing that usually brings the beginner, as well as a willingness to go very hard, to quickly abandon things that are not working,” he said. “He lives this week, and the result of this week’s result.”

To continue in Manas on Monday, the company has already approached five different strategic partners, Hoffman said.

Hoffman said the company “quick to build” and “learn and spread” mode. One of the initial initiatives is called the Cosmos project, which is an effort to map the basic rules of drug link, depending on the company’s website. Hoffman refused to share more details about the project.

Today ManaS has only four employees – including Hoffman and Mukherjee – but Hoffman said it grows. The company has played like “AI” while serving as “Bio Guy”, “he said. In the end, ManaS is melting the two fields.

“It’s not the best science and it’s not the best of the air, because one of these two is not enough,” Hoffman said. “You have to put these two together.”

As ai guy, Hoffman put a lot of attention this week in the depths of Chinese depths in the US

Deepsee began to create roar in January, when the starting point was created, when he released the R1 R1 Open model R1, Openai O1 rivals. Model Openai, anthropic, anthrophic, developed part of the cost of the rivalry models of the rivals. Google And others.

Hoffman said Deepsek could be encouraged by the company to share the rhythm and share the rhythm as soon as new revelations suggest that large models are a bad investment.

“The competition game is turned,” he said, “But I don’t think ‘Oh my God, we’re losing!” As American technology. “

See: LinkedIn Co-Founder Reid Hoffman at Deepseeke